WHO recommends use of first malaria vaccine for children
The decision followed a review of a pilot programme deployed since 2019 in Ghana, Kenya and Malawi where more than two million doses were given of the vaccine, first made by the pharmaceutical company GSK in 1987.
The vaccine acts against plasmodium falciparum -- one of five parasite species and the most deadly.
Malaria symptoms include fever, headaches and muscle pain, then cycles of chills, fever and sweating.
Every two minutes, a child dies of malaria, according to the World Health Organization.
Before the newly recommended vaccine can reach African children, the next step will be funding.
"That will be the next major step... Then we will be set up for scaling of doses and decisions about where the vaccine will be most useful and how it will be deployed," said Kate O'Brien, Director of WHO’s Department of Immunization, Vaccines and Biologicals